Decreased Capacity to Metabolize Diphenylhydantoin in a Patient with Hypersensitivity to Warfarin
- 1 October 1975
- journal article
- case report
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 5 (5) , 462-466
- https://doi.org/10.1111/j.1445-5994.1975.tb03058.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Acute Intoxication with 5,5-Diphenylhydantoin (Dilantin®) Associated with Impairment of BiotransformationAnnals of Internal Medicine, 1972
- Intoxication with 5,5-diphenylhydantoin (Dilantin): Clinical features, blood levels, urinary metabolites, and metabolic changes in a childThe Journal of Pediatrics, 1972
- Warfarin metabolism in man: identification of metabolites in urineJournal of Clinical Investigation, 1970
- Genetic control of dicumarol levels in manJournal of Clinical Investigation, 1968
- VARIATIONS IN METABOLISM OF COUMARIN ANTICOAGULANT DRUGSAnnals of the New York Academy of Sciences, 1968
- Management of Epilepsy With Diphenylhydantoin SodiumPublished by American Medical Association (AMA) ,1968
- The anticoagulant response to bishydroxycoumarin: I. The role of individual variationClinical Pharmacology & Therapeutics, 1967
- Crystallization and Preliminary Characterization of a Dicoumarol Metabolite in the Faeces of Dicoumarol‐Treated RatsActa Pharmacologica et Toxicologica, 1966
- Insufficient parahydroxylation as a cause of diphenylhydantoin toxicityNeurology, 1964
- STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*Journal of Clinical Investigation, 1963